DRD3 Antikörper (AA 213-329)
-
- Target Alle DRD3 Antikörper anzeigen
- DRD3 (Dopamine Receptor D3 (DRD3))
-
Bindungsspezifität
- AA 213-329
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DRD3 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Aufreinigung
- Antigen Affinity Chromatography
- Immunogen
- Recombinant human D (3) dopamine receptor protein (213-329AA).
- Isotyp
- IgG
- Top Product
- Discover our top product DRD3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.3, containing 0.02 % sodium azide and 50 % Glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- DRD3 (Dopamine Receptor D3 (DRD3))
- Andere Bezeichnung
- DRD3 (DRD3 Produkte)
- Synonyme
- DRD3 antikoerper, D3R antikoerper, D3DR antikoerper, ETM1 antikoerper, FET1 antikoerper, dopamine receptor D3 antikoerper, drd3 antikoerper, DRD3 antikoerper, Drd3 antikoerper
- Gen-ID
- 1814
- UniProt
- P35462
- Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Negative Regulation of Transporter Activity
-